Facial Lipoatrophy
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Croma-PharmaAustria - Leobendorf
2 programsPrincess® FILLERN/A1 trial
Princess® VOLUMEN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Croma-PharmaPrincess® VOLUME
Croma-PharmaPrincess® FILLER
Bausch HealthSCULPTRA
Clinical Trials (3)
Total enrollment: 399 patients across 3 trials
Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
Start: Nov 2016Est. completion: Mar 201856 patients
N/ACompleted
Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
Start: Nov 2016Est. completion: Jan 201853 patients
N/ACompleted
Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
Start: Oct 2005Est. completion: Aug 2011290 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.